Trusted Resources

Brief SummaryThe purpose of this study is to characterize cardiac safety of Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone (D-VCd) treatment regimens…

BACKGROUND Amyloidosis results in fibrillar sheets of beta-pleated amorphous congophilic protein deposition in the extracellular space. Breast amyloidosis is a rare…

BackgroundThe introduction of a noninvasive diagnostic algorithm in 2016 led to increased awareness and recognition of cardiac amyloidosis (CA).ObjectivesThe…

At AstraZeneca, we are committed to driving healthcare system transformation to improve outcomes for patients living with amyloidosis around the world. The launch…

Patients undergoing trigger release surgery are known to be at increased risk of amyloidosis and heart failure, and therefore, amyloidosis screening during trigger…

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of amyloidosisexternal link, opens in a new tab, which is a group of diseases where abnormal…

IntroductionLight chain (AL) amyloidosis is a rare and complex disease which can affect various systems of the body. In common with many rare and multisystemic…

Cardiac amyloidosis, increasingly recognized for its significant impact on global heart health and patient survival, demands a thorough review to understand its…

Cardiac amyloidosis results in a restrictive cardiomyopathy caused by extracellular deposition of proteins in the myocardium. The proteins have an unstable…

If you’re one of the millions of Americans who suffer from carpal tunnel syndrome (CTS), you may want to speak to your doctor about your heart health. A new study…